Register for the live webinar now!
If you are having trouble reading this email, read the online version | | | | Getting your CBD brand ready for regulation
How to think about the cannabinoid category in the twilight of FDA purgatory
|
|---|
|
| |
|
|
| | When it comes to regulating CBD, the FDA has prioritized pharmaceutical monopoly over public health, leaving the consuming public and honest brands to fend for themselves. And with its recent rejection of “full spectrum” New Dietary Ingredient Notifications, the Agency has only pushed its head further into the sand. Join Justin Singer, CEO & Co-Founder of Caliper Foods, for this complimentary webinar, where he’ll review how we got here, and what’s next for a category that’s waiting—and waiting—for responsible unlock.
Dont miss out - register today! |
Francine Schoenwetter
Content Marketing Director
Informa Markets Health & Nutrition | | Justin Singer
CEO & Co-Founder
Caliper Foods |
|---|
|
| |
|
This email was sent to you by the Informa Markets Division of Informa PLC (Privacy Policy).
Informa PLC's registered office is 5 Howick Place, London SW1P 1WG.
Registered in England and Wales. Number 8860726.
If you do not wish to receive further information from us, please click here.
Alternatively, to contact our data services team to have your details or preferences updated please email [email protected]. 